ERAS Insider Trading Activity and SEC Form 4 Filings
ERAS insider trading summary
Over the past 12 months, insiders at Erasca, Inc. (ERAS) reported 3 sales worth $2.3M by 2 insiders and no open-market purchases on SEC Form 4. Net insider selling was $2.3M.
Latest ERAS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 1, 2026 | Ebun Garner | Chief Legal Officer | Sell | $1.3M (80,000 @ $16.40) |
| Mar 4, 2026 | Shannon Morris | Chief Medical Officer | Sell | $301K (20,000 @ $15.04) |
| Jan 7, 2026 | Ebun Garner | General Counsel & Corp. Sec. | Sell | $671K (120,000 @ $5.59) |
| May 21, 2024 | Alexander W. Casdin | Director | Buy | $182K (80,000 @ $2.27) |
| Dec 6, 2023 | Valerie Denise Harding Start | Director | Buy | $18K (10,000 @ $1.85) |
| Dec 6, 2023 | Jonathan E Lim | Chairman & CEO | Buy | $478K (278,150 @ $1.72) |
| Dec 5, 2023 | Jonathan E Lim | Chairman & CEO | Buy | $1.2M (721,850 @ $1.69) |
| Dec 4, 2023 | Alexander W. Casdin | Director | Buy | $50K (30,000 @ $1.66) |
| Oct 5, 2023 | Jonathan E Lim | Chairman & CEO | Buy | $2.0M (1,000,000 @ $2.03) |
| Jun 8, 2023 | Jonathan E Lim | Chairman & CEO | Buy | $275K (100,000 @ $2.75) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.